• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨髓移植后患者的骨髓基质功能。

Bone marrow stromal function from patients after bone marrow transplantation.

作者信息

O'Flaherty E, Sparrow R, Szer J

机构信息

Clinical Haematology and Bone Marrow Transplantation, Alfred Hospital, Prahran, Victoria, Australia.

出版信息

Bone Marrow Transplant. 1995 Feb;15(2):207-12.

PMID:7539666
Abstract

A two-stage long-term bone marrow culture (LTBMC) has been used to assess haemopoietic supporting ability from patients following allogeneic bone marrow transplantation (BMT). Irradiated confluent LTBMCs derived from recipients following BMT were recharged with flow cytometry sorted CD34+/CD38- cells from normal BM donors. The output of granulocyte/macrophage colony-forming cells (GM-CFC) in the non-adherent fraction of the cultures was monitored weekly until output ceased. Patient stromal cell function was determined by comparing the percentage of the total cumulative GM-CFC output to the output from normal control stroma. Neutrophil recovery was rapid and complete early in the post-transplant period. However, in contrast, GM-CFC recovery was significantly reduced in all patients up to 5 years after BMT. In 58% of patients studied following BMT the BM stroma is considerably compromised in its ability to support early uncommitted haemopoietic cells contained within the CD34+/CD38- cell fraction of normal BM. Bone marrow stroma from BMT recipients exhibited severe deficits in their abilities to support primitive haemopoietic cells and in some patients this effect lasted for several years. While the growth of stroma from patients following BMT was severely delayed and often incomplete, characterisation of cells types using APAAP techniques did not show significant differences in proportion when compared with normal cultures.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

两阶段长期骨髓培养(LTBMC)已被用于评估异基因骨髓移植(BMT)后患者的造血支持能力。对BMT后受者来源的经辐照的汇合LTBMC,用来自正常骨髓供体的经流式细胞术分选的CD34+/CD38-细胞进行再填充。每周监测培养物非贴壁部分中粒细胞/巨噬细胞集落形成细胞(GM-CFC)的产出,直至产出停止。通过比较总累积GM-CFC产出的百分比与正常对照基质的产出,来确定患者基质细胞功能。移植后早期中性粒细胞恢复迅速且完全。然而,相比之下,BMT后长达5年的所有患者中GM-CFC恢复均显著降低。在BMT后接受研究的患者中,58%的患者骨髓基质支持正常骨髓CD34+/CD38-细胞部分中早期未定向造血细胞的能力受到相当大的损害。BMT受者的骨髓基质在支持原始造血细胞方面表现出严重缺陷,在一些患者中这种影响持续数年。虽然BMT后患者的基质生长严重延迟且往往不完全,但与正常培养物相比,使用碱性磷酸酶抗碱性磷酸酶(APAAP)技术对细胞类型进行表征时,比例上未显示出显著差异。(摘要截短于250字)

相似文献

1
Bone marrow stromal function from patients after bone marrow transplantation.骨髓移植后患者的骨髓基质功能。
Bone Marrow Transplant. 1995 Feb;15(2):207-12.
2
Hematopoietic progenitor cells from allogeneic bone marrow transplant donors circulate in the very early post-transplant period.来自异基因骨髓移植供体的造血祖细胞在移植后的极早期就在循环中出现。
Bone Marrow Transplant. 1999 Apr;23(7):659-65. doi: 10.1038/sj.bmt.1701638.
3
Alterations in both the hematopoietic microenvironment and the progenitor cell population follow the recovery from myeloablative therapy and bone marrow transplantation.造血微环境和祖细胞群体的改变都发生在清髓性治疗和骨髓移植后的恢复过程中。
Exp Hematol. 1995 Dec;23(14):1661-6.
4
Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.正常的骨髓造血干细胞储备和正常的基质细胞功能支持在多发性硬化症患者中使用自体干细胞移植。
Bone Marrow Transplant. 2005 Dec;36(12):1053-63. doi: 10.1038/sj.bmt.1705179.
5
Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.异基因骨髓移植后骨髓及循环长期培养起始细胞的持久减少。
Bone Marrow Transplant. 1999 May;23(10):1029-37. doi: 10.1038/sj.bmt.1701759.
6
Thrombopoietin enhances neutrophil production by bone marrow hematopoietic progenitors with the aid of stem cell factor in congenital neutropenia.在先天性中性粒细胞减少症中,血小板生成素借助干细胞因子增强骨髓造血祖细胞的中性粒细胞生成。
J Leukoc Biol. 2000 Jul;68(1):137-43.
7
In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.骨髓移植后CFU-GM和BFU-E对肿瘤坏死因子-α和干扰素-γ的体外敏感性
Exp Hematol. 1995 Dec;23(14):1422-30.
8
The murine stromal cell line AFT024 acts specifically on human CD34+CD38- progenitors to maintain primitive function and immunophenotype in vitro.小鼠基质细胞系AFT024特异性作用于人CD34+CD38-祖细胞,以在体外维持其原始功能和免疫表型。
Exp Hematol. 1998 Jul;26(7):612-9.
9
Phenotypic and functional characterization of committed and primitive myeloid and lymphoid hematopoietic precursors in human fetal liver.人胎肝中定向和原始髓系及淋巴系造血前体细胞的表型和功能特征
Exp Hematol. 1997 May;25(5):387-94.
10
The membrane-bound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietic cells in long-term cultures of normal and aplastic anemia bone marrow.干细胞因子的膜结合异构体与可溶性fms样酪氨酸激酶3配体协同作用,在正常和再生障碍性贫血骨髓的长期培养中支持早期造血细胞。
Exp Hematol. 1998 May;26(5):365-73.

引用本文的文献

1
Mesenchymal stem/stromal cells from a transplanted, asymptomatic patient with Fanconi anemia exhibit an aging-like phenotype and dysregulated expression of genes implicated in hematopoiesis and myelodysplasia.来自一名患有范可尼贫血症的无症状移植患者的间充质干细胞/基质细胞表现出类似衰老的表型和造血及骨髓增生异常相关基因表达失调。
Cytotherapy. 2023 Apr;25(4):362-368. doi: 10.1016/j.jcyt.2022.11.003. Epub 2022 Dec 5.
2
Human Wharton's jelly stem cells, its conditioned medium and cell-free lysate inhibit the growth of human lymphoma cells.人牙髓间充质干细胞、其条件培养基和无细胞裂解物抑制人淋巴瘤细胞的生长。
Stem Cell Rev Rep. 2014 Aug;10(4):573-86. doi: 10.1007/s12015-014-9514-3.
3
Reconstruction of hematopoietic inductive microenvironment after transplantation of VCAM-1-modified human umbilical cord blood stromal cells.
VCAM-1 修饰的人脐血基质细胞移植后造血诱导微环境的重建。
PLoS One. 2012;7(2):e31741. doi: 10.1371/journal.pone.0031741. Epub 2012 Feb 23.
4
Concise review: hitting the right spot with mesenchymal stromal cells.简明综述:直击间充质基质细胞的要害。
Stem Cells. 2010 Aug;28(8):1446-55. doi: 10.1002/stem.459.
5
Mesenchymal stem cells for bone repair and metabolic bone diseases.用于骨修复和代谢性骨病的间充质干细胞。
Mayo Clin Proc. 2009 Oct;84(10):893-902. doi: 10.4065/84.10.893.
6
Effect of ex vivo culture of CD34+ bone marrow cells on immune reconstitution of XSCID dogs following allogeneic bone marrow transplantation.CD34+骨髓细胞体外培养对异基因骨髓移植后XSCID犬免疫重建的影响。
Biol Blood Marrow Transplant. 2009 Jun;15(6):662-70. doi: 10.1016/j.bbmt.2009.03.014.
7
Effect of mesenchymal stem cell transplantation on the engraftment of human hematopoietic stem cells and leukemic cells in mice model.间充质干细胞移植对小鼠模型中人类造血干细胞和白血病细胞植入的影响。
Int J Hematol. 2008 Apr;87(3):327-37. doi: 10.1007/s12185-008-0041-3. Epub 2008 Feb 22.
8
Application of stem cells in bone repair.干细胞在骨修复中的应用。
Skeletal Radiol. 2008 Jul;37(7):601-8. doi: 10.1007/s00256-007-0438-8. Epub 2008 Jan 12.
9
Mesenchymal stem cells in stem cell transplant recipients are damaged and remain of host origin.干细胞移植受者体内的间充质干细胞受损,且仍来源于宿主。
Int J Hematol. 2005 Aug;82(2):152-8. doi: 10.1532/IJH97.A10505.
10
[Therapy-related changes of angiogenesis in Philadelphia chromosome positive chronic myelogenous leukemia].[费城染色体阳性慢性髓性白血病中血管生成的治疗相关变化]
Pathologe. 2004 Mar;25(2):127-34. doi: 10.1007/s00292-003-0677-y.